immune evasion, tumor

Showing 1 - 3 of 3

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)

Recruiting
  • Cancer of Unknown Primary
  • +5 more
  • Tislelizumab plus chemotherapy
  • Shanghai, Shanghai, China
    ChangZheng Hospital
Feb 6, 2022

Relapse Leukemia, Allogeneic Stem Cell Transplantation, Immune Evasion, Tumor Trial (blood sample, bone marrow sample)

Unknown status
  • Relapse Leukemia
  • +2 more
  • blood sample
  • bone marrow sample
  • (no location specified)
May 24, 2019

Immune Evasion, Tumor, Neoplastic Cells, Circulating, Circulating Tumor Cell Trial in Bordeaux (RFA interventions)

Unknown status
  • Immune Evasion, Tumor
  • +4 more
  • RFA interventions
  • Bordeaux, France
    Institut Bergonie
May 21, 2019